Correlation Between Neurocrine Biosciences and Pacira BioSciences,

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Pacira BioSciences,, you can compare the effects of market volatilities on Neurocrine Biosciences and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Pacira BioSciences,.

Diversification Opportunities for Neurocrine Biosciences and Pacira BioSciences,

0.02

Correlation Coefficient

Neurocrine Biosciences  Pacira BioSciences,

Significant diversification

The 3 months correlation between Neurocrine and Pacira is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Pacira BioSciences,

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 16.88 times less return on investment than Pacira BioSciences,. But when comparing it to its historical volatility, Neurocrine Biosciences is 1.42 times less risky than Pacira BioSciences,. It trades about 0.0 of its potential returns per unit of risk. Pacira BioSciences, is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,556  in Pacira BioSciences, on August 30, 2024 and sell it today you would earn a total of  108.00  from holding Pacira BioSciences, or generate 6.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Neurocrine Biosciences  vs.  Pacira BioSciences,

Neurocrine Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Neurocrine Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pacira BioSciences,

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Pacira BioSciences, may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Neurocrine Biosciences and Pacira BioSciences,

The main advantage of trading using opposite Neurocrine Biosciences and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.

The idea behind Neurocrine Biosciences and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.